Amphetamine Stimulant Prodrug denied for missing prior authorization by Cigna?

Cigna's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Issued a Prior-Authorization Denial

Cigna requires prior authorization (PA) for amphetamine-class stimulant prodrugs because these medications carry a significant potential for misuse and are subject to both federal controlled-substance regulations and insurer utilization-management programs. A PA denial typically means either that authorization was not obtained before the prescription was filled, or that a PA request was submitted but did not satisfy Cigna's clinical criteria as documented.

## Your Appeal Rights

A PA denial is a fully appealable coverage decision. Under ACA §2719, you are entitled to an internal appeal and, if that is unsuccessful, an independent external review. ERISA §503 provides equivalent protections for most employer-sponsored plans. You generally have approximately four months from the final internal denial to request external review. If your condition is urgent, request the expedited track — a decision is required within 72 hours.

## Appeal Process and Timeline

1. Obtain the denial in writing with the specific clinical criteria that were not met. 2. Contact your prescriber immediately — PA appeals nearly always require the prescriber to lead or co-sign the submission because clinical documentation must come from the treating provider. 3. File the internal appeal within Cigna's deadline (commonly 180 days). Cigna must issue a decision within 30 days (pre-service) or 60 days (post-service). 4. Escalate to external review if the internal appeal is denied. Request the independent review organization (IRO) process through Cigna or your state regulator.

## Documentation to Gather

• Diagnosis confirmation: Current office notes establishing the qualifying diagnosis (e.g., ADHD) with DSM or equivalent criteria documented.
• Prior treatment history: A dated list of other treatments previously tried, including duration and reason for discontinuation or inadequate response.
• Clinical severity: Chart notes documenting how the condition affects daily functioning, occupational performance, or safety.
• Prescriber medical-necessity letter: A letter stating the diagnosis, clinical rationale for this specific drug over alternatives, and attestation that the patient meets the criteria in Cigna's published PA policy.
• Cigna's PA criteria: Download the current prior-authorization requirements from Cigna's website or request them from the denial letter. Map each criterion to a specific chart entry.

## Criteria-Mapping Structure

List every PA criterion from Cigna's published policy in the left column of a table. In the right column, provide the exact evidence from the chart that satisfies each requirement — visit date, note content, test result, or prescriber statement. This side-by-side structure is the single most effective tool in a PA appeal because it forces the reviewer to address each criterion individually rather than issuing a blanket denial.